首页> 外文期刊>Oncology reports >Analysis of microRNA expression profiles reveals a 5-microRNA prognostic signature for predicting overall survival time in patients with gastric adenocarcinoma
【24h】

Analysis of microRNA expression profiles reveals a 5-microRNA prognostic signature for predicting overall survival time in patients with gastric adenocarcinoma

机译:MicroRNA表达型谱的分析揭示了5微米的预后签名,用于预测胃腺癌患者的整体存活时间

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

There is growing evidence supporting dysregulated microRNAs (miRNAs) as potential prognostic biomarkers in cancer. The present study aimed to identify an miRNA model set with prognostic power for patients with gastric adenocarcinoma. miRNA-seq data from 155 patients and 37 controls were downloaded from The Cancer Genome Atlas (TCGA) database for a comprehensive analysis of miRNA expression profiles and were used as training data. A total of 5 prognostic miRNAs, which have not been previously reported, were identified using univariate and multivariate Cox regression analyses. A separate 155-patient TCGA cohort was used as a validation set for evaluation of the risk model. Patients in the training set were assigned into high- and low-risk groups according to the 5-miRNA signature risk scores. Kaplan-Meier survival analyses demonstrated that patients with high risk scores had significantly shorter survival times than those with low risk scores. The risk model validation confirmed the prognostic ability of this 5-miRNA signature in predicting the risk status of patients. Stratification analysis for clinical prognostic variables demonstrated recurrence and age were significant prognostic factors in the low- and high-risk groups, respectively. In conclusion, the present 5-miRNA signature is a potential independent risk factor for patient outcomes. The risk model based on the 5-miRNA signature performed well in predicting overall survival time in patients with gastric adenocarcinoma.
机译:存在越来越多的证据,支持令人困惑的微小RNA(miRNA)作为癌症的潜在预后生物标志物。本研究旨在鉴定胃腺癌患者预后功率的miRNA模型。从155名患者和37个对照的MiRNA-SEQ数据从癌症基因组Atlas(TCGA)数据库下载,以综合分析miRNA表达谱,并用作培训数据。使用单变量和多变量COX回归分析鉴定了总共尚未报道的预后MIRNA。单独的155患者TCGA队列用作评估风险模型的验证集。培训集中的患者根据5-miRNA签名风险评分分配到高风险群体中。 Kaplan-Meier生存率分析证明,具有高风险评分的患者的生存时间明显短于风险评分低的生存时间。风险模型验证证实了这种5- miRNA签名预测患者风险状况的预后能力。对临床预后变量的分层分析表明,复发和年龄分别是低风险群体中的显着预后因素。总之,目前的5-miRNA签名是患者结果的潜在的独立危险因素。基于5-miRNA签名的风险模型在预测胃腺癌患者的总生存时间方面表现良好。

著录项

  • 来源
    《Oncology reports》 |2019年第5期|共15页
  • 作者单位

    Jilin Univ Hosp 1 Dept Gastroenterol 71 Xinmin St Changchun 130021 Jilin Peoples R China;

    Jilin Univ Hosp 1 Dept Med Insurance Management Changchun 130021 Jilin Peoples R China;

    Jilin Univ Hosp 1 Dept Gastroenterol 71 Xinmin St Changchun 130021 Jilin Peoples R China;

    Jilin Univ Hosp 1 Dept Gastroenterol 71 Xinmin St Changchun 130021 Jilin Peoples R China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 肿瘤学;
  • 关键词

    gastric adenocarcinoma; risk model; microRNA; survival time;

    机译:胃腺癌;风险模型;microRNA;生存时间;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号